MT1 (Melanotan-I) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that has garnered attention in research for its role in skin pigmentation and photoprotection. This compound primarily interacts with the melanocortin-1 receptor (MC1R), making it a valuable tool for studying eumelanin production and its associated biological pathways, including antioxidant and anti-inflammatory mechanisms.

Pigmentation and Photoprotection

Melanotan-I enhances eumelanin synthesis in melanocytes, contributing to increased pigmentation that is more resistant to ultraviolet (UV) radiation. This effect may lead to reduced UV-induced erythema and DNA damage in experimental models.
The compound is also investigated for its potential in managing photosensitivity conditions and mitigating the risks associated with actinic damage by promoting epidermal melanin production and improving the skin’s redox balance.

Anti-inflammatory and Neuroprotective Applications

Research indicates that activation of MC1R by Melanotan-I may result in decreased expression of pro-inflammatory cytokines and matrix remodeling factors in both dermal and hepatic cell models.
Preclinical studies suggest that Melanotan-I may have implications for neuroinflammation, astrocyte function, and amyloid-related pathology, positioning it as a compound of interest in cognitive and neurodegenerative research.

For research and laboratory use only. Not for human consumption.